Status:
UNKNOWN
Effect of Time-restricted Eating on Blood Glucose and Behavior in Patients With Type 2 Diabetes Mellitus
Lead Sponsor:
Peking University Third Hospital
Conditions:
Type 2 Diabetes Mellitus
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
Diet management could improve blood and weight control in patients with diabetes mellitus. Time-restricted feeding is a novel dietary tool that limits time of energy intake without altering diet quali...
Eligibility Criteria
Inclusion
- Diagnosed with type 2 diabetes mellitus
- HbA1c 7.0% to 8.5%
- BMI ≥ 24 kg/m2
- Time of energy intake ≥ 12 hours per day, ≥ 4 days per week
- Ability to use smart phone and app, to follow study protocol
- Sign informed consent
Exclusion
- Use insulin, long-acting insulin secretagogues, GLP-1 receptor agonist, DPP-4 inhibitor, SGLT-2 inhibitor
- Suffer from disease influence eating: mental disease, subtotal gastrectomy, inflammatory bowel disease, uncontrolled thyroid disease
- Work state affect eating time: constant night duty, constant long-haul international travel
- Smoking
- Drinking
- Severe disease: severe cardiovascular and cerebrovascular disease, uncontrolled arrhythmia, heart failure, acute and chronic renal dysfunction, liver cirrhosis, malignancy, anemia
- Suffered from infectious disease: pulmonary tuberculosis, AIDS
- Dyskinesia
- Body weight change ≥ 5 kg in the past 3 months
- Hospitalized in the past 3 months
- Used antibiotics for ≥ 3 days in the past 3 months
- Diagnosed with type 1 diabetes mellitus
- Pregnancy, lactating
- Participating in other clinical trials in the past 1 months
Key Trial Info
Start Date :
April 15 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2022
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT04841837
Start Date
April 15 2021
End Date
December 1 2022
Last Update
June 22 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Peking University Third Hospital
Beijing, China